MGC Pharma is hoping to bring more surprises to the market in the next few years.
India Globalization hopes the formula could provide relief for the potential 50 million people across the globe which are expected to be impacted by Alzheimer’s disease by 2030
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
Paul Pedersen is the co-founder and CEO of Nextleaf Solutions, an extraction-only cannabis company based in Vancouver, BC. Traded under the symbol OILS
Innovating in the Medical Cannabis Space is a way to highlight the unique innovations happening in the Canadian sector as
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
